Chimeric Antigen Receptor (CAR) T cell therapy is a revolutionary approach in the field of cancer immunotherapy.
Chimeric Antigen Receptor (CAR) T Cell Therapy
![Chimeric Antigen Receptor (CAR) T Cell Therapy Chimeric Antigen Receptor (CAR) T Cell Therapy](https://www.caltagmedsystems.co.uk/information/wp-content/uploads/Chimeric-Antigen-Receptor-CAR-T-Cell-Therapy-image-600x300.png)
Chimeric Antigen Receptor (CAR) T cell therapy is a revolutionary approach in the field of cancer immunotherapy.
AllCells’ has thousands of well-characterised, highly engaged recallable donors, with specific attributes, at collection sites across the US & Europe.
AllCells’ Pre-Characterised Donor Selection Program expedites screening, selecting & collecting from donors for downstream clinical manufacturing.
Key takeaways from AllCells’ VP of Donor Operations presentation on reframing the donor supply chain ecosystem to support the CGT manufacturing boom.
AllCells and Discovery continue to expand their solutions alongside the CGT industry to help researchers overcome roadblocks.